Ross Doehrmann, DO
Orthopaedic Surgery · Clive, IANPI 1255869103
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.9%), grants and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 41.9% of the total. Reporting peaked in 2023 at $16,499 and has fallen 98.4% since, to $267 in 2025. Among orthopaedic surgery clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $664.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- Smith+Nephew$11K
- Pinnacle, Inc$4K
- Stryker$575
- Zimmer Biomet$471
- Xiros Inc$444
- plus $821 from 7 others
What the payments were for
- Grants$10,00035%
- Travel & lodging$7433%
- Food & beverage$2,7009%
- Education$15,11453%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 6 | $11,967 |
| Smith+Nephew | 7 | $10,658 |
| Pinnacle, Inc | 6 | $3,621 |
| Stryker | 10 | $575 |
| Zimmer Biomet | 4 | $471 |
| Xiros Inc | 2 | $444 |
| Exactech, Inc. | 1 | $172 |
| Prism Medical | 1 | $150 |
| Wardlow Enterprises | 2 | $129 |
| Medinc Of Texas | 1 | $124 |
| Skeletal Dynamics Inc | 1 | $114 |
| Endo Pharmaceuticals Inc. | 1 | $113 |
| Medacta USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Comprehensive Shoulder System$227
- EQUINOXE$172
- REUNION$164
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$158
- Bioinductive Implant with Arthroscopic Delivery System - Medium$140
- REAL INTELLIGENCE$129
- Journey II$129
- Persona$129
- Geminus$114
- Align$114
- IJS$114
- Implate$114
- Biomet Total Femur$114
- XIAFLEX$113
- PITCH-PATCH$107
How this compares
$28,557 in reported general payments places this provider in the 90th percentile of 219 orthopaedic surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 33 | $469 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $328 |
| Meloxicam | 71 | $227 |
| Methocarbamol | 24 | $89 |
| Doxycycline Hyclate | 19 | $74 |
| Tramadol Hcl | 27 | $69 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Clive
- Mark FishClive$25K
- John CallaghanIowa City$23.3M
- Brian AdamsIowa City$865K
- Cesar de Cesar NettoIowa City$693K
- Lynn NelsonBelmond$285K
- Robert WestermannIowa City$182K
- Joseph BuckwalterIowa City$132K
- Brendan PattersonIowa City$122K
- Nicholas BedardIowa City$59K
- Charles ClarkIowa City$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.